Skip to main content
Erschienen in: Journal of Anesthesia 3/2016

07.03.2016 | Short Communication

A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal

verfasst von: Hajime Iwasaki, Tomoki Sasakawa, Kenichi Takahoko, Shunichi Takagi, Hideki Nakatsuka, Takahiro Suzuki, Hiroshi Iwasaki

Erschienen in: Journal of Anesthesia | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

We report the use of rocuronium to re-establish neuromuscular block after reversal with sugammadex. The aim of this study was to investigate the relationship between the dose of rocuronium needed to re-establish neuromuscular block and the time interval between sugammadex administration and re-administration of rocuronium. Patients who required re-establishment of neuromuscular block within 12 h after the reversal of rocuronium-induced neuromuscular block with sugammadex were included. After inducing general anesthesia and placing the neuromuscular monitor, the protocol to re-establish neuromuscular block was as follows. An initial rocuronium dose of 0.6 mg/kg was followed by additional 0.3 mg/kg doses every 2 min until train-of-four responses were abolished. A total of 11 patients were enrolled in this study. Intervals between sugammadex and second rocuronium were 12–465 min. Total dose of rocuronium needed to re-establish neuromuscular block was 0.6–1.2 mg/kg. 0.6 mg/kg rocuronium re-established neuromuscular block in all patients who received initial sugammadex more than 3 h previously. However, when the interval between sugammadex and second rocuronium was less than 2 h, more than 0.6 mg/kg rocuronium was necessary to re-establish neuromuscular block.
Literatur
1.
Zurück zum Zitat Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41:266–70.CrossRefPubMed Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41:266–70.CrossRefPubMed
2.
Zurück zum Zitat Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg. 2007;104:575–81.CrossRefPubMed Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg. 2007;104:575–81.CrossRefPubMed
3.
Zurück zum Zitat Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JHM, Hermens Y, Mirakhur RK. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009;110:284–94.PubMed Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JHM, Hermens Y, Mirakhur RK. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009;110:284–94.PubMed
4.
Zurück zum Zitat Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg. 2007;104:555–62.CrossRefPubMed Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg. 2007;104:555–62.CrossRefPubMed
5.
Zurück zum Zitat de Boer HD, Driessen JJ, Marcus MAE, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex—a multicenter, dosefinding and safety study. Anesthesiology. 2007;107:239–44.CrossRefPubMed de Boer HD, Driessen JJ, Marcus MAE, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex—a multicenter, dosefinding and safety study. Anesthesiology. 2007;107:239–44.CrossRefPubMed
6.
Zurück zum Zitat Cammu G, de Kam PJ, De Graeve K, van den Heuvel M, Suy K, Morias K, Foubert L, Grobara P, Peeters P. Repeat dosing of rocuronium 1.2 mg kg−1 after reversal of neuromuscular block by sugammadex 4.0 mg kg−1 in anaesthetized healthy volunteers: a modelling-based pilot study. Br J Anaesth. 2010;105:487–92.CrossRefPubMed Cammu G, de Kam PJ, De Graeve K, van den Heuvel M, Suy K, Morias K, Foubert L, Grobara P, Peeters P. Repeat dosing of rocuronium 1.2 mg kg−1 after reversal of neuromuscular block by sugammadex 4.0 mg kg−1 in anaesthetized healthy volunteers: a modelling-based pilot study. Br J Anaesth. 2010;105:487–92.CrossRefPubMed
7.
Zurück zum Zitat Matsuki G, Takahata O, Iwasaki H. Repeat dosing of rocuronium after reversal of neuromuscular block by sugammadex. Can J Anaesth. 2011;58:769–70.CrossRefPubMed Matsuki G, Takahata O, Iwasaki H. Repeat dosing of rocuronium after reversal of neuromuscular block by sugammadex. Can J Anaesth. 2011;58:769–70.CrossRefPubMed
8.
Zurück zum Zitat Fabregat-Lopez J, Veiga-Ruiz G, Dominguez-Serrano N, Garcia-Martinez MR. Re-establishment of neuromuscular block by rocuronium after sugammadex administration. Can J Anaesth. 2011;58:658–9.CrossRefPubMed Fabregat-Lopez J, Veiga-Ruiz G, Dominguez-Serrano N, Garcia-Martinez MR. Re-establishment of neuromuscular block by rocuronium after sugammadex administration. Can J Anaesth. 2011;58:658–9.CrossRefPubMed
9.
Zurück zum Zitat Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103:695–703.CrossRefPubMed Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103:695–703.CrossRefPubMed
10.
Zurück zum Zitat Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007;62:806–9.CrossRefPubMed Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007;62:806–9.CrossRefPubMed
11.
Zurück zum Zitat Di Marco P, Della Rocca G, Iannuccelli F, Pompei L, Reale C, Pietropaoli P. Knowledge of residual curarization: an Italian survey. Acta Anaesthesiol Scand. 2010;54:307–12.CrossRefPubMed Di Marco P, Della Rocca G, Iannuccelli F, Pompei L, Reale C, Pietropaoli P. Knowledge of residual curarization: an Italian survey. Acta Anaesthesiol Scand. 2010;54:307–12.CrossRefPubMed
12.
Zurück zum Zitat Futter M, Gin T. Neuromuscular block: views from the Western Pacific. Anesth Analg. 2010;111:11–2. Futter M, Gin T. Neuromuscular block: views from the Western Pacific. Anesth Analg. 2010;111:11–2.
13.
Zurück zum Zitat Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013;117:345–51.CrossRefPubMed Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013;117:345–51.CrossRefPubMed
14.
Zurück zum Zitat Pongracz A, Szatmari S, Nemes R, Fulesdi B, Tassonyi E. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. Anesthesiology. 2013;119:36–42.CrossRefPubMed Pongracz A, Szatmari S, Nemes R, Fulesdi B, Tassonyi E. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. Anesthesiology. 2013;119:36–42.CrossRefPubMed
15.
Zurück zum Zitat Schaller SJ, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology. 2010;113:1054–60.CrossRefPubMed Schaller SJ, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology. 2010;113:1054–60.CrossRefPubMed
16.
Zurück zum Zitat Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? Can J Anaesth. 2007;54:689–95.CrossRefPubMed Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? Can J Anaesth. 2007;54:689–95.CrossRefPubMed
17.
Zurück zum Zitat de Boer HD, Driessen JJ, van Egmond J, Booij LH. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Can J Anaesth. 2008;55:124–5 (author reply 5–6). de Boer HD, Driessen JJ, van Egmond J, Booij LH. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Can J Anaesth. 2008;55:124–5 (author reply 5–6).
Metadaten
Titel
A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal
verfasst von
Hajime Iwasaki
Tomoki Sasakawa
Kenichi Takahoko
Shunichi Takagi
Hideki Nakatsuka
Takahiro Suzuki
Hiroshi Iwasaki
Publikationsdatum
07.03.2016
Verlag
Springer Japan
Erschienen in
Journal of Anesthesia / Ausgabe 3/2016
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-016-2159-4

Weitere Artikel der Ausgabe 3/2016

Journal of Anesthesia 3/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.